Adi Alajem

1.4k total citations
9 papers, 1.0k citations indexed

About

Adi Alajem is a scholar working on Molecular Biology, Cancer Research and Biomedical Engineering. According to data from OpenAlex, Adi Alajem has authored 9 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 1 paper in Cancer Research and 1 paper in Biomedical Engineering. Recurrent topics in Adi Alajem's work include Genomics and Chromatin Dynamics (5 papers), Pluripotent Stem Cells Research (4 papers) and CRISPR and Genetic Engineering (4 papers). Adi Alajem is often cited by papers focused on Genomics and Chromatin Dynamics (5 papers), Pluripotent Stem Cells Research (4 papers) and CRISPR and Genetic Engineering (4 papers). Adi Alajem collaborates with scholars based in Israel, United States and Singapore. Adi Alajem's co-authors include Eran Meshorer, Miguel Ramalho‐Santos, Alexandre Gaspar‐Maia, Mike J. Mason, Michael T. McManus, João Ramalho‐Santos, Fanny Polesso, Amy Heidersbach, Rupa Sridharan and Kathrin Plath and has published in prestigious journals such as Nature, Nature Reviews Molecular Cell Biology and Developmental Cell.

In The Last Decade

Adi Alajem

9 papers receiving 996 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adi Alajem Israel 7 932 85 82 74 51 9 1.0k
Irena Koutná Czechia 17 550 0.6× 120 1.4× 100 1.2× 52 0.7× 83 1.6× 52 699
Efrat Oron Israel 9 738 0.8× 82 1.0× 74 0.9× 62 0.8× 104 2.0× 10 856
Shan Sabri United States 9 921 1.0× 142 1.7× 46 0.6× 116 1.6× 50 1.0× 11 1.0k
Jumpei Nogami Japan 16 636 0.7× 62 0.7× 38 0.5× 93 1.3× 29 0.6× 29 732
Hiroki Ura Japan 12 849 0.9× 160 1.9× 51 0.6× 123 1.7× 86 1.7× 40 989
Nicola Festuccia France 17 1.3k 1.4× 238 2.8× 130 1.6× 90 1.2× 49 1.0× 20 1.4k
Abdenour Soufi United Kingdom 13 1.5k 1.6× 155 1.8× 109 1.3× 111 1.5× 96 1.9× 18 1.6k
Viktoria Andreeva United States 9 438 0.5× 170 2.0× 53 0.6× 32 0.4× 47 0.9× 14 561
Vidur Garg United States 10 920 1.0× 60 0.7× 29 0.4× 195 2.6× 64 1.3× 20 1.0k
Fabienne De Graeve France 12 451 0.5× 104 1.2× 37 0.5× 47 0.6× 93 1.8× 16 553

Countries citing papers authored by Adi Alajem

Since Specialization
Citations

This map shows the geographic impact of Adi Alajem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adi Alajem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adi Alajem more than expected).

Fields of papers citing papers by Adi Alajem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adi Alajem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adi Alajem. The network helps show where Adi Alajem may publish in the future.

Co-authorship network of co-authors of Adi Alajem

This figure shows the co-authorship network connecting the top 25 collaborators of Adi Alajem. A scholar is included among the top collaborators of Adi Alajem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adi Alajem. Adi Alajem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Alajem, Adi, et al.. (2022). Esrrb is a cell-cycle-dependent associated factor balancing pluripotency and XEN differentiation. Stem Cell Reports. 17(6). 1334–1350. 14 indexed citations
2.
Alajem, Adi, et al.. (2021). DNA methylation patterns expose variations in enhancer-chromatin modifications during embryonic stem cell differentiation. PLoS Genetics. 17(4). e1009498–e1009498. 11 indexed citations
3.
Bavli, Danny, Xue Sun, Alva Biran, et al.. (2021). CloneSeq: A highly sensitive analysis platform for the characterization of 3D-cultured single-cell-derived clones. Developmental Cell. 56(12). 1804–1817.e7. 5 indexed citations
4.
Gutin, Jenia, Ronen Sadeh, Daphna Joseph-Strauss, et al.. (2018). Fine-Resolution Mapping of TF Binding and Chromatin Interactions. Cell Reports. 22(10). 2797–2807. 35 indexed citations
5.
Lev-Maor, Galit, Adi Alajem, Arnab Datta, et al.. (2015). SF3B1 Association with Chromatin Determines Splicing Outcomes. Cell Reports. 11(4). 618–629. 78 indexed citations
6.
Alajem, Adi, Alva Biran, Arigela Harikumar, et al.. (2015). Differential Association of Chromatin Proteins Identifies BAF60a/SMARCD1 as a Regulator of Embryonic Stem Cell Differentiation. Cell Reports. 10(12). 2019–2031. 39 indexed citations
7.
Gaspar‐Maia, Alexandre, Adi Alajem, Eran Meshorer, & Miguel Ramalho‐Santos. (2011). Erratum: Open chromatin in pluripotency and reprogramming. Nature Reviews Molecular Cell Biology. 12(4). 273–273. 3 indexed citations
8.
Gaspar‐Maia, Alexandre, Adi Alajem, Eran Meshorer, & Miguel Ramalho‐Santos. (2010). Open chromatin in pluripotency and reprogramming. Nature Reviews Molecular Cell Biology. 12(1). 36–47. 429 indexed citations
9.
Gaspar‐Maia, Alexandre, Adi Alajem, Fanny Polesso, et al.. (2009). Chd1 regulates open chromatin and pluripotency of embryonic stem cells. Nature. 460(7257). 863–868. 387 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026